Bisantrene is a targeted agent.
BGN: Bisantrene is a failed chemotherapy drug. Companies are all developing targeted agents now.
Mason: well, Bis is actually a first-in-class targeted agent with a heap of history
BGN: chemotherapy is the devil because it is so toxic to patients
Mason: well, Bisantrene is actually a first-in-class targeted agent that has off-target effects that protect against the toxicity of the most used chemotherapy drug in the world
BGN: doesn't matter, this is a failed venture because chemo is too toxic and the millions of people with cancer should wait for targeted therapies to be approved for their specific cancer type
You have fantasy and reality all mixed up
Industry news, page-2178
-
- There are more pages in this discussion • 387 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
0.055(3.62%) |
Mkt cap ! $268.4M | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.56 | $106.0K | 67.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 649 | $1.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 3000 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |